Komori
General Meetings of Shareholders8750Daiichi Life Group,Inc.Financials (excluding banks)

Our Views on the ISS Report

Following ISS's recommendation against the reappointment of 3 director candidates, the Company published its views seeking shareholder support for their reappointment. The Company explained that the 3 candidates remain suitable to serve as directors based on the progress made in implementing measures to prevent recurrence, business performance, and their contributions to enhancing corporate value.

Worth reading
—
Scored from 0 of 4 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
17.9
% (year-on-year change in annualized premiums from domestic new contracts for FY2025)
Wording
Conditional
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (16th fiscal period)
2026
Jun 22
Date and time(start time: Not disclosed)18 days from this disclosure to the meeting
Matters for resolution1 item
  1. Election of 10 directors, excluding directors who are Audit & Supervisory Committee Members

Director nominee10 people (new: Not disclosed; outside: Not disclosed)
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (16th fiscal period)
Date and time22 June 2026 (start time: Not disclosed)
Matters for resolutionProposal No. 2: Election of 10 directors, excluding directors who are Audit & Supervisory Committee Members
Director nominee10 people (new: Not disclosed; outside: Not disclosed)
Items this document does not state (2)
Shareholder ProposalPercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company has implemented measures to prevent recurrence following inappropriate information-gathering incidents involving insurance agencies, including suspending employee secondments and strengthening its management framework. Domestic annualized premiums from new contracts for FY2025 increased 17.9% year on year, indicating strong business performance, and the Company is steadily advancing its business transformation toward FY2030.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Our Views on the ISS Report | Daiichi Life Group,Inc. (8750) timely disclosure | Komori